Corey McCann - 16 Feb 2022 Form 4 Insider Report for Pear Therapeutics, Inc.

Role: President and CEO, Director
Signature: /s/ Stacie S. Aarestad, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 16 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 18 Feb 2022, 15:40:54 UTC
Previous filing: 07 Dec 2021
Next filing: 18 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PEARQ	Class A Common Stock						8,157,565	16 Feb 2022	Direct	F1
holding	PEARQ	Class A Common Stock						1,685,913	16 Feb 2022	by The Corey M. McCann Irrevocable Trust of 2021	F2, F3
holding	PEARQ	Class A Common Stock						986,517	16 Feb 2022	by The McCann Family Trust	F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PEARQ	Stock Option (Right to Buy)	Award	$0	+210,080		$0.000000	210,080	16 Feb 2022	Common Stock	210,080	$4.06	Direct	F5
transaction	PEARQ	Restricted Stock Units	Award	$0	+266,667		$0.000000	266,667	16 Feb 2022	Common Stock	266,667		Direct	F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Updated to correct error in prior Form 4 filing.
F2	The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, with respect to these shares, except to the extent of his pecuniary interest therein.
F3	Shares held in The Corey M. McCann Irrevocable Trust of 2021. The trustee of The Corey M. McCann Irrevocable Trust of 2021 is Mia E. Moll.
F4	Shares held in The McCann Family Trust. The trustee of The McCann Family Trust is Concord Trust Company.
F5	25% of the shares underlying the option shall vest on January 14, 2023 and an additional 2.0833 and 1/3% of the shares shall vest on the last day of each calendar month thereafter.
F6	Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
F7	The restricted stock units shall vest and settle as to 33% of the shares on January 14, 2023, 33% of the shares on January 14, 2024 and the final 34% on January 14, 2025.